Circulation-Genomic and Precision Medicine is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of cardiology, cardiovascular medicine, and genetics. With an impressive impact factor and ranked in the Q1 quartile across multiple categories, including Cardiology and Genetics, this journal is pivotal for researchers and professionals seeking the latest insights and advancements in precision medicine. Established in 2018, it has rapidly gained recognition, evidenced by its commendable Scopus ranking and high percentiles among related fields. The journal emphasizes open access to enhance the dissemination of knowledge, making cutting-edge research readily available to a global audience. With the convergence of genomic science and cardiovascular health, Circulation-Genomic and Precision Medicine aims to foster interdisciplinary collaborations, offering a vital platform for innovative studies that impact patient care and clinical practices.

GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.

GENETICS, published by the Genetics Society of America, stands as a preeminent journal in the field of genetics, with a keen focus on advancing the understanding of genetic principles and their implications across various biological systems. Since its inception in 1945, the journal has played a pivotal role in disseminating groundbreaking research, maintaining a Q1 ranking in the genetics category as of 2023, positioning it among the top tier of academic publications. While access to the journal is not open, it continues to attract a global readership of researchers, professionals, and students eager to engage with high-quality, peer-reviewed articles that span both classical and contemporary genetics. With its publication history covering critical decades from 1945 to 2024, GENETICS is not just a repository of scientific knowledge but a vibrant forum for the exchange of ideas that drive the field forward. The journal’s commitment to excellence is demonstrated by its strategic coverage of pertinent topics, assuring its relevance for future generations of scholars.

Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

Human Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.

CA: A Cancer Journal for Clinicians is a prestigious academic journal published by Wiley, serving as a leading source of evidence-based information for those in the fields of oncology and hematology. With an impressive impact factor and ranked in the top quartile (Q1) for both specialties, this journal aims to bridge the gap between the latest research findings and clinical practice. Established in 1950, it boasts a long-standing history of delivering essential insights, guidelines, and innovative strategies to healthcare professionals worldwide, making significant contributions to the understanding and treatment of cancer. Although it does not offer open access, its published content is crucial for researchers, clinicians, and students dedicated to advancing cancer care. The journal's commitment to excellence is reflected in its elite rankings, holding the #1 position in both the Medicine – Oncology and Medicine – Hematology categories according to Scopus, positioning it in the 99th percentile of scholarly impact.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.